NCT00109291View on ClinicalTrials.gov

Safety of Single Doses of Peginesatide in Patients With Chronic Kidney Disease

PHASE2TerminatedINTERVENTIONAL

Enrollment

17

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

February 28, 2006

Study Completion Date

February 28, 2006

Conditions

AnemiaChronic Kidney DiseaseChronic Renal Failure

Interventions

DRUG

Placebo

DRUG

peginesatide

Trial Locations (1)

Unknown

Research Facility, London

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Affymax

INDUSTRY